The Emerging Markets Cancer Ignition Fund (“EMCIFund”) is an oncology focused venture capital fund that leverages a pre-validated pathway between established and emerging markets to overcome critical bottlenecks in the therapeutic development lifecycle. EMCIFund exponentially accelerates value inflection points for oncology focused start-ups and expand global access to cutting-edge cancer solutions.
| Website | https://emcifund.com/ |
| Employees | 7 (4 on RocketReach) |
| Founded | 2022 |
| Industry | Venture Capital & Private Equity |
| Keywords | Oncology Investment, Healthcare Venture Capital, Venture Capital, Cancer Therapeutics, Cancer Research Funding, Emerging Market Healthcare, Emerging Markets, Biotechnology Fund, Biotechnology Investment, Clinical Stage Investment, Pharmaceutical Venture Capital, Pharmaceutical Investment, Life Science Investing, Therapeutic Development, Drug Development |
| Competitors | PayPal, Upstart, LendingClub, Prosper Marketplace, Funding Circle UK, Lendio, Kiva, Indiegogo, StreetShares (Acquired by MeridianLink; NYSE: MLNK), PANGEA +40 more (view full list) |
Looking for a particular EMCIFund employee's phone or email?
Himabindu Gaddipati is the Founder and Managing Partner of EMCIFund.
4 people are employed at EMCIFund.
EMCIFund is based in San Diego, California.